Wednesday, November 25, 2009, 11:59am EST - Canadian Markets close in 4 hours and 1 minute.
To create a watchlist or portfolio of shares, Sign-in or Register

Immtech Pharmaceuticals, Inc. (IMM)

 On May 13: 0.42 USD  Down 0.04 (8.70%)  
MORE ON IMM
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
IMMTECH PHARM INC (AMEX:IMM) Delayed quote dataEdit
Last Trade: 0.42 USD
Trade Time: May 13
Change: Down 0.04 (8.70%)
Prev Close: 0.46
Open: 0.45
Bid: N/A
Ask: N/A
1y Target Est: 11.00
Day's Range: 0.38 - 0.47
52wk Range: 0.06 - 1.64
Volume: 56,444
Avg Vol (3m): 34,546.8
Market Cap: 7.13M
P/E (ttm): N/A
EPS (ttm): -0.90
Div & Yield: N/A (N/A%)
Immtech Pharmaceuticals, Inc. (IMM)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add IMM to Portfolio   Download Data

HEADLINES
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
EDGAR Online (Thu, May 21)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Apr 21)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
EDGAR Online (Thu, Apr 2)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statemen
EDGAR Online (Fri, Mar 6)
• IMMTECH PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Wed, Feb 18)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Feb 9)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements
EDGAR Online (Tue, Jan 20)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisiti
EDGAR Online (Fri, Jan 16)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
EDGAR Online (Tue, Dec 30)
• IMMTECH PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 10)
More Headlines for IMM...
ANALYST
EPS Est (next year) (Mar-08) : N/A
EPS Est (in 2 years) (Mar-09) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Immtech Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of oral drugs to treat infectious diseases in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices